<DOC>
	<DOC>NCT01444729</DOC>
	<brief_summary>An agreement has been made to conduct a post-approval commitment study that provides supplementary information relating to the use of XiapexÂ® as well as other non-pharmacological treatments for Dupuytren's contracture by health care professionals in a real world clinical setting.</brief_summary>
	<brief_title>Post Approval Commitment Study</brief_title>
	<detailed_description>phase 4, open label, multi-center, prospective non-interventional descriptive</detailed_description>
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Dupuytren Contracture</mesh_term>
	<criteria>Adults with a palpable cord eligible for the treatment of Dupuytren's contracture</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>'Dupuytren's contracture'</keyword>
	<keyword>'xiapex'</keyword>
	<keyword>'surgery'</keyword>
</DOC>